Product NDC: | 68462-209 |
Proprietary Name: | Moexipril Hydrochloride |
Non Proprietary Name: | Moexipril Hydrochloride |
Active Ingredient(s): | 7.5 mg/1 & nbsp; Moexipril Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68462-209 |
Labeler Name: | Glenmark Generics Inc., USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090416 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101231 |
Package NDC: | 68462-209-10 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE (68462-209-10) |
NDC Code | 68462-209-10 |
Proprietary Name | Moexipril Hydrochloride |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE (68462-209-10) |
Product NDC | 68462-209 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Moexipril Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20101231 |
Marketing Category Name | ANDA |
Labeler Name | Glenmark Generics Inc., USA |
Substance Name | MOEXIPRIL HYDROCHLORIDE |
Strength Number | 7.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |